Black Rock Inc. Blueprint Medicines Corp Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Black Rock Inc. holds 6,647,297 shares of BPMC stock, worth $861 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
6,647,297
Previous 6,447,461
3.1%
Holding current value
$861 Million
Previous $612 Million
17.14%
% of portfolio
0.02%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding BPMC
# of Institutions
46Shares Held
8.67MCall Options Held
8Put Options Held
151K-
Pictet Asset Management Sa Geneva 73, V8724KShares$93.7 Million0.05% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL419KShares$54.3 Million0.01% of portfolio
-
Eagle Asset Management Inc St Petersburg, FL155KShares$20 Million0.09% of portfolio
-
Ghost Tree Capital, LLC New York, NY140KShares$18.1 Million4.85% of portfolio
-
Chi Advisors LLC New York, NY92.9KShares$12 Million2.3% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $7.73B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...